Vol. 23 No. 2 (2021): Off-label drugs against Covid-19 in Latin America

					View Vol. 23 No. 2 (2021): Off-label drugs against Covid-19 in Latin America

The COVID-19 pandemic represents one of the most important challenges in public health’s history. Severity of the clinical picture and lack of supporting scientific evidence have led to compassionate use of off-label medications. Indiscriminate use of these medications, however, can be harmful for patients.

Published: 2021-07-01

Artículos de revisión

Reportes de caso